See every side of every news story
Published loading...Updated

Chronic Hives Study - Allergy & Asthma Network

The focus of this study is to evaluate the efficacy of an investigational drug, EVO756, in adults with moderate to severe CSU, and how safely it interacts with the body. Participants will receive either the study drug or placebo in tablet form to take for 12 weeks and be evaluated on an outpatient basis. The...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

allergyasthmanetwork.org broke the news in on Monday, June 23, 2025.
Sources are mostly out of (0)